Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Clinical trial NCT00543049 · COMPLETED

Trial details

NCT number: NCT00543049
Sponsor: AGO Study Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum Refractory Epithelial Ovarian Cancer Primary Cancer of the Peritoneum Cancer of the Fallopian Tube

Start date: 2007-09-01
Primary completion: 2012-06-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.